twiggs462.bsky.social
@twiggs462.bsky.social
Reposted
🚨NEW EPISODE🚨 How do perception and language shape subjectivity? What makes an experience ineffable? And can LSD offer new prospects for treating MDD and GAD? We're joined by @dankarlin.com of MindMed to talk new research trials, neurobiology, and more! www.buzzsprout.com/2131830/epis...
121: LSD: Subjectivity, Ineffability, and Mental Health feat. Dan Karlin - Ordinary Unhappiness
Abby and Patrick continue their series on psychedelics via an in-depth interview with Dr. Dan Karlin. Karlin is a psychiatrist and Chief Medical Officer at MindMed, where he oversees clinical trials u...
www.buzzsprout.com
November 8, 2025 at 3:04 PM
Reposted
The first version of #MalditaCastilla was released 13 years ago today!

A dark fantasy sidescroller packed with myths from Spain and inspired by a bunch of mid-to-late 80s arcade games I love. Featuring a super on point FM soundtrack by @gryzor87.bsky.social

Info: locomalito.com
December 12, 2025 at 6:02 PM
Reposted
“This is important: if #LSD represents a sort of magic, it is a magic of the modern West, in all its horror and promethean glory. For all its alchemical resonance, it sprouts from the brow of industrial chemistry …” aeon.co/essays/how-o...
How outlaw chemists used ‘blotter’ to dose the world with LSD | Aeon Essays
How perforated squares of trippy blotter paper allowed outlaw chemists and wizard-alchemists to dose the world with LSD
aeon.co
May 10, 2024 at 12:11 PM
$MNMD MindMed Third Quarter 2024 Financial Results & Business Updates

Initiating Phase 3 for Generalized Anxiety Disorder (GAD)

Initiateg Phase 3 for Major Depressive Disorder (MDD)

Cash $295.3 million; fund operations into 2027

ir.mindmed.co/news-events/...

#psychedelics #stock #biotech
MindMed Reports Third Quarter 2024 Financial Results and Business Updates
--On track to initiate the Phase 3 Voyage study of MM120 Orally Disintegrating Tablet (ODT) in Generalized Anxiety Disorder (GAD) in the…...
ir.mindmed.co
November 10, 2024 at 2:56 PM
@bethmariem.bsky.social Have you checked into this company MindMed? Could be something interesting to write about on Ars.

MindMed.co
November 10, 2024 at 5:36 AM
Reposted
$MNMD MindMed (NASDAQ: MNMD) Q3 Snapshot: Advancing Three Phase 3 Trials with Ample Cash
MNMD Q3 Snapshot: Advancing Three Phase 3 Trials with Ample Cash
New York, November 08, 2024 - PRISM MarketView - MindMed (NASDAQ: MNMD) reported its third quarter 2024 financial results and provided significant business updates, highlighting its progress towards…
buff.ly
November 8, 2024 at 4:01 PM